
Evotec, Boehringer Ingelheim, and bioMérieux launch Aurobac
Aurobac Therapeutics SAS goal is to create next-generation antimicrobials and diagnostics to fight Antimicrobial Resistance (AMR). Decades ago, drug...

Avantium gets EU grant
Avantium said it will use the EU grant from the Horizon Europe programme for its participation in the 4-year research and development programme...

$50m for London CHARM Therapeutics for deep minded folding expertise
London based CHARM Therapeutics rushes into the 3D deep-learning space with a $50M Series A financing co-led by F-Prime Capital and OrbiMed, with...

GSK splits off consumer health as Haleon - first stock listing today
Glaxo's consumer healthcare business is currently a joint venture between GSK, which owns 68% and Pfizer (PFE), which has 32%. The demerger...

CureVac NV sues BioNTech for IP infringement
On Monday, CureVac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech SE and two of its subsidiaries, seeking compensation...

BIONTech breaks ground for manufacturing site in Rwanda
According to BioNtech, the facility will be initially equipped with two BioNTainers, and is expected to employ about 100 staff by 2024. However, the...

French Ipsen falls after Epizyme take-over announcement
Even if Ipsen succeeds in halving the losses at Epizyme Inc, this would reduce the group's profit by nine percent by 2024, Credit Suisse analysts...